Letters
NICE on statins
Statins for all? A question for society
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4192 (Published 09 July 2014) Cite this as: BMJ 2014;349:g4192
- David Barer, geriatrician/stroke physician1
- 1South of Tyne and Wear Stroke Collaboration, Sunderland Royal Hospital, Sunderland SR4 7TP, UK
- david.barer{at}ncl.ac.uk
The debate about extending the use of statins to those with an (unreliably) estimated 1% annual risk of cardiovascular disease is degenerating into an unseemly row about side effects,1 2 3 largely promoted by the tabloid press on one side and drug companies on the other. This is a dispute that the medical profession should keep out of, at least until the relevant evidence is …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.